<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144/A</submissionType>
<previousAccessionNumber>0000950170-24-132336</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001409751</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001261654</issuerCik>
<issuerName>Universal Technical Institute, Inc.</issuerName>
<secFileNumber>001-31923</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">4225 East Windrose Drive</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 200</street2>
<city xmlns="http://www.sec.gov/edgar/common">Phoenix</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">AZ</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">85032</zipCode>
</issuerAddress>
<issuerContactPhone>623-445-9500</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Coliseum Capital Management, LLC</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Owner</relationshipToIssuer>
<relationshipToIssuer>Director</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Morgan Stanley &amp; Co. LLC</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">1585 Broadway</street1>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10036</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>3188460</noOfUnitsSold>
<aggregateMarketValue>92784186</aggregateMarketValue>
<noOfUnitsOutstanding>53811817</noOfUnitsOutstanding>
<approxSaleDate>12/02/2024</approxSaleDate>
<securitiesExchangeName>NYSE</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>06/24/2016</acquiredDate>
<natureOfAcquisitionTransaction>Purchases directly from Issuer and Open Market Purchases</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Issuer and Open Market Purchases</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>3188460</amountOfSecuritiesAcquired>
<paymentDate>06/24/2016</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<remarks>This Amendment No. 1 to Form 144 (this "Amendment") is being filed to update the amount of securities to be sold reported in the original Form 144, which was transmitted for filing on December 2, 2024. The "Number of Shares . . . To Be Sold" includes 2,483,579 shares sold on the date of such original Form 144.

The securities referred herein are held directly by (a) Coliseum Capital Partners, L.P., an investment limited partnership of which Coliseum Capital, LLC ("CC") is general partner and for which Coliseum Capital Management, LLC ("CCM") serves as investment adviser and (b) a separate account investment advisory client of CCM. Christopher Shackelton and Adam Gray are managers of and have ownership interest in each of CCM and CC. Shackelton is a director of the Issuer.

For the "Securities Information" table, the "Aggregate Market Value" is based on closing price of the Common Stock on February 10, 2025 of $29.10 per share.</remarks>
<noticeSignature>
<noticeDate>02/10/2025</noticeDate>
<signature>/s/ Chivonne Cassar, as Attorney-in-Fact</signature>
</noticeSignature>
</formData>
</edgarSubmission>
